Shh pathway receptor agonist enhanced blood flow recovery in type 1 diabetic mice.
Shh pathway receptor agonist improved EPC function in type 1 diabetic mice.
The Shh signaling pathway was impaired in diabetic EPCs.
The Shh and PI3K/AKT pathways showed cross-talk in EPCs.